Genetic Engineering Publications - GEG Tech top picks
36.6K views | +0 today
Follow
Genetic Engineering Publications - GEG Tech top picks
Your new post is loading...
Your new post is loading...
Scooped by BigField GEG Tech
Scoop.it!

Hybrid human–chicken embryos illuminate key developmental milestone - Nature

Hybrid human–chicken embryos illuminate key developmental milestone - Nature | Genetic Engineering Publications - GEG Tech top picks | Scoop.it
A new technique reveals the earliest stages of human development without the need for human embryos.
BigField GEG Tech's insight:

For the first time, researchers have watched human ‘organizer’ cells direct the formation of an embryo’s top, bottom, front and back. They did so by developing a technique that sidesteps restrictions on research with human embryos by grafting human cells onto chicken embryos. The method, published on 23 May in Nature1, could supplant the use of human embryos in some laboratory experiments.

No comment yet.
Scooped by BigField GEG Tech
Scoop.it!

CRISPR: a versatile tool for both forward and reverse genetics research

CRISPR: a versatile tool for both forward and reverse genetics research | Genetic Engineering Publications - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

In the review, the authors provide a perspective on the power of CRISPR-based forward and reverse genetics tools in human genetics and discuss its applications using some disease examples.

No comment yet.
Scooped by BigField GEG Tech
Scoop.it!

Chinese scientists to pioneer first human CRISPR trial

Chinese scientists to pioneer first human CRISPR trial | Genetic Engineering Publications - GEG Tech top picks | Scoop.it
Gene-editing technique to treat lung cancer is due to be tested in people in August.
BigField GEG Tech's insight:

Chinese scientists are on the verge of being first in the world to inject people with cells modified using the CRISPR–Cas9 gene-editing technique.

A team led by Lu You, an oncologist at Sichuan University’s West China Hospital in Chengdu, plans to start testing such cells in people with lung cancer next month. The clinical trial received ethical approval from the hospital's review board on 6 July.

No comment yet.